Phase 2Data readout

IPN10200 (Long-Acting Toxin)

Cervical Dystonia

IPSEYIpsen

Expected catalystDecember 31, 2026Company guidance: Dec 31, 2026

Catalyst overview

Event details

Drug or asset: IPN10200 (Long-Acting Toxin)
Development stage: Phase 2
Event type: Data readout
Indication: Cervical Dystonia

Research summary

What is being tracked?

This catalyst tracks a Phase 2 data readout for IPN10200 (Long-Acting Toxin) in Cervical Dystonia. The expected timing is based on the latest available company guidance and may change.

Development notes

07/30/26:- PR No update.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Source URL not provided

IPN10200 (Long-Acting Toxin)

Event details

What is being tracked?

Development notes

Primary source

Related pipeline programs

Navtemadlin (MDM2 Inhibitor)

Odevixibat (ileal bile acid transport inhibitor)

Dysport/AbobotulinumtoxinA (Botulinum Neurotoxin)

IPN10200